Stockreport

NeuroPace Completes Enrollment in Feasibility Study of RNS System for Lennox-Gastaut Syndrome [Yahoo! Finance]

Neuropace, Inc.  (NPCE) 
PDF MOUNTAIN VIEW, Calif., Dec. 03, 2024 (GLOBE NEWSWIRE) -- NeuroPace, Inc. (Nasdaq: NPCE), a commercial-stage medical device company focused on transforming the lives of [Read more]